Reduction in High Rates of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease in Tennessee after Introduction of the Pneumococcal Conjugate Vaccine | Zendy

Thomas R. Talbot | Zendy; Katherine A. Poehling | Zendy; Tina V. Hartert | Zendy; Patrick G. Arbogast | Zendy; Natasha Halasa | Zendy; M Ed | Zendy; William Schaffner | Zendy; Allen S. Craig | Zendy; Kathryn M. Edwards | Zendy; Marie R. Griffin | Zendy

Open Access

Reduction in High Rates of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease in Tennessee after Introduction of the Pneumococcal Conjugate Vaccine

Author(s) -

Thomas R. Talbot,

Katherine A. Poehling,

Tina V. Hartert,

Patrick G. Arbogast,

Natasha Halasa,

M Ed,

William Schaffner,

Allen S. Craig,

Kathryn M. Edwards,

Marie R. Griffin

Publication year - 2004

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/422653

Subject(s) - medicine , pneumococcal conjugate vaccine , streptococcus pneumoniae , serotype , vaccination , antibiotics , penicillin , epidemiology , pediatrics , pneumococcal infections , pneumococcal disease , conjugate vaccine , immunization , virology , immunology , microbiology and biotechnology , biology , antibody

Invasive pneumococcal disease (IPD) is a burgeoning problem, with rates of antibiotic-nonsusceptible IPD, in particular, increasing during the past decade. One measure to combat IPD is vaccination with the recently introduced 7-valent pneumococcal conjugate vaccine (PCV).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research